|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Fatigue strength improvement by ultrasonic impact treatment of highly stressed spokes of cast aluminium wheels显示文摘 | POLLACK A B VOELLMECKE F J SONSINO C M | 2011 | International Journal of Fatigue2011,33,4: | 1 |
| 2 | Idarucizumab for dabigatran reversal 显示文摘 | Pollack C V Reilly P A Eikelboom J | 2015 | N Engl J Med2015,373,6: | 1 |
| 3 | Genome-wide analysis of DNA copy-number changes using cDNA microarrays显示文摘 | PEROU C M | 1999 | Nat Genet1999,23,: | 1 |
| 4 | Cardiac troponins 显示文摘 | SARKO J POLLACK C V J R | 2002 | J Emerg Med2002,23,1: | 1 |
| 5 | The effects of the soy isoflavone genistein on the reproductive development of striped bass显示文摘 | Pollack S J Ottinger M A Sullivan C V | 2003 | North American Journal of Aquaculture2003,65,3: | 1 |
| 6 | Clevidipine,an intravenous dihydropyridine calcium channel bloc-ker,is safe and effective for the treatment of patients with acute severe hypertension显示文摘 | Pollack C V Varon J Garrison N A et at | 2009 | Annals of Emergency Medicine2009,53,3: | 1 |
| 7 | Intrapleural urokinase in the treatment of loculated pleural effusions显示文摘 | POLLACK J S PASSlK C S | 1994 | Chest1994,105,: | 1 |
| 8 | Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone显示文摘 | Cole C J Pollack A Zagars GK | 1995 | Int J Radiat Oncol Biol Phys1995,32,2: | 1 |
| 9 | Project manage- ment in construction: soitware use and research directions 显示文摘 | Liberatore M J Pollack J B Simth C A | 2001 | Journal of construction engineering and management2001,127,2: | 1 |
| 10 | Anisotropic nonconservative scattering and the clouds ofVenus显示文摘 | Sagan C Pollack J B | 1967 | J GeophysRes1967,72,2: | 1 |
| 11 | Heavy metal toxicity, part Ⅰ: arsenic and mercury显示文摘 | GRAEME K A POLLACK J C V | 1998 | Journal of Emergency Medicine1998,16,: | 1 |
| 12 | Heavy metal toxicity, part Ⅱ: lead and metal fume fever显示文摘 | GRAEME K A POLLACK J C V | 1998 | Journal of Emergency Medicine1998,16,: | 1 |
| 13 | Volcanic explosions and climatic change: A theoretical assessment 显示文摘 | Pollack J B Toon O B Sagan C | 1976 | J Geophy Res1976,81,10: | 1 |
| 14 | Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia显示文摘BACKGROUND Sleep disturbance is a core feature of post-traumatic stress disorder(PTSD).Given the relationship between sleep disturbance and PTSD,there has been a relative paucity of studies examining the potential therapeutic impact of using pharmacotherapy to target sleep disturbance in patients with PTSD.Eszopiclone(ESZ)is a non-benzodiazepine y-aminobutyric acid-A receptor agonist indicated for the treatment of sleep and may affect sleep in patients with PTSD.AIM To evaluate the efficacy of ESZ vs placebo(PBO)for patients with PTSD and insomnia.METHODS The study was a 12-wk,double blind,randomized controlled trial with 3 mg of ESZ(n=13)or PBO(n=12).RESULTS Patients in both arms experienced significant improvement in PTSD symptoms as assessed by the Clinician-Administered PTSD Scale for DSM-IV(CAPS):ESZ(t11=-3.12,P=0.005)and PBO(t11=-3.5,P=0.002)and by self-report with the Short PTSD Rating Interview(ESZ t11=-3.38,P=0.003 and PBO t11=-4.48,P=0.0005).There were no significant differences between treatments on the CAPS(t22=-0.13,P=0.70)or the Short PTSD Rating Interview(t22=-0.58,P=0.56).Similarly,both treated groups improved on sleep measures as assessed by the Pittsburgh Sleep Quality Index with PTSD Addendum(PSQI)and on total sleep time(TST)and sleep latency assessed by actigraphy with no significant differences between groups(PSQI t22=-0.24,P=0.81;total sleep time t10=0.13,P=0.90 and sleep latency t10=0.68,P=0.50).There was a significant correlation between improvement in sleep and overall improvement in PTSD as measured by change scores on the PSQI and CAPS,r(8)=0.79,P=0.01 for ESZ treated subjects,but not for those treated with PBO r(9)=0.16,P=0.69.Adverse events of ESZ were consistent with the known profile of the medication including dysgeusia(30%,mild),sedation(20%,mild)and headache(20%,moderate to severe).CONCLUSION Results do not support the hypothesis of a specific positive effect of ESZ compared to PBO for measures of PTSD and associated sleep disturbance. | Sheila M Dowd Alyson K Zalta Helen J Burgess Elizabeth C Adkins Zerbrina Valdespino-Hayden Mark H Pollack | 2020 | World Journal of Psychiatry2020,10,3: | 1 |
| 15 | Anthropogenic albedo changes and the earth's climate显示文摘 | Sagan C Toom O B Pollack J B | 1979 | Science1979,,206: | 1 |
| 16 | Use of plain radiography to screen for cervical spine injuries 显示文摘 | Mower W R Hoffman J R Pollack C V Jr | 2001 | Ann Emerg Med2001,38,1: | 1 |
| 17 | Ischemia modified albumin (IMA) is useful in risk stratification of emergency department chest painpatients显示文摘 | Pollack C V J r Peacock W F Summers R W et at | 2003 | Acad Emerg reed2003,10,5: | 1 |
| 18 | Uptake and efllux of the peptidic delta-opioid receptor agonist显示文摘 | DAGENAIS C DUCHARME J POLLACK GM | 2001 | Neurosci Lett2001,301,3: | 1 |
| 19 | Intrapleural urokinase in the treatment of locuated pleural effusions显示文摘 | Pollack J S Passik C S | 1994 | Chest1994,105,: | 1 |
| 20 | Modern freshwatermicrobialite analogues for ancient dendritic reef structures 显示文摘 | Laval B Cady S L Pollack J C | 2000 | Nature2000,407,: | 1 |